Editorial
Published on 30 Sep 2024
Editorial: Multimodality therapy for older cancer patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1487783
- 475 views
Type at least 3 characters
1,880 articles
Review
Published on 30 Sep 2024
Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1409383
- 1,149 views
Case Report
Published on 26 Sep 2024
Case report: Tenosynovial giant cell tumor
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1445427
- 1,909 views
Original Research
Published on 19 Sep 2024
Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1425895
- 1,902 views
Mini Review
Published on 17 Sep 2024
Bridging the gap: advancing cancer cell culture to reveal key metabolic targets
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1480613
- 1,626 views
- 1 citation
Original Research
Published on 13 Sep 2024
Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1440906
- 1,244 views
Review
Published on 13 Sep 2024
Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1437542
- 3,700 views
Original Research
Published on 12 Sep 2024
USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1427663
- 1,021 views
Mini Review
Published on 12 Sep 2024
ABHD5 as a friend or an enemy in cancer biology?
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1447509
- 1,408 views
Original Research
Published on 09 Sep 2024
Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1452282
- 1,118 views
Editorial
Published on 06 Sep 2024
Editorial: Theranostics as a driving force in nuclear medicine
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1468357
- 800 views
Case Report
Published on 03 Sep 2024
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1450889
- 814 views
Original Research
Published on 30 Aug 2024
Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1442601
- 1,348 views
Review
Published on 26 Aug 2024
Targeted anti-angiogenesis therapy for advanced osteosarcoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1413213
- 1,827 views
- 3 citations
Original Research
Published on 23 Aug 2024
Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1448890
- 1,471 views
Review
Published on 22 Aug 2024
Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1445191
- 2,202 views